Ladenburg Thalmann initiated coverage of German-based Evotec (FSE:EVT) with a “buy” rating and price target of €22.50. The stock closed at €18.53 on Oct. 3. Evotec is a global drug discovery and services company that...
IntelGenx’s (TSXV:IGX; OTCQX:IGXT) partner, Insud Pharma (formerly Chemo Group), submitted an abbreviated new drug application (ANDA) with the FDA for a generic buccal film product. “The filing of an ANDA for this...
H.C. Wainwright raised its price target for STRATA Skin Sciences (NASDAQ:SSKN) to $5 from $3 after the company announced new clinical data that is expected to drive patient growth and retention. The stock closed at $3...
Stifel resumed coverage of Inovio Pharmaceuticals (NASDAQ:INO) with a “buy” rating and $8 price target, saying the implied risk/reward appears palatable. The stock closed at $5.35 on Oct. 1. Analyst Steven Willey writes...
Titan Pharmaceuticals (NASDAQ:TTNP) appointed Dane Hallberg to the newly created position of EVP and chief commercial officer, effective immediately, with responsibility for leading all of the company’s commercial...
Ladenburg Thalmann launched coverage of Oncolytics Biotech (NASDAQ:ONCY) with a “buy” rating and $22 price target. The stock closed at $3.86 on Sept. 28. Oncolytics is developing oncolytic virus (OV) therapy for cancer...